Nobivac Rabies Vaccine

Verify with FDA CVM →

10 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
1
Deaths Reported
1000.0%
Death Rate

Active Ingredients

Nobivac Rabies Vaccine

Administration Routes

UnknownSubcutaneous

Species Affected

Dog 8
Cat 2

Most Affected Breeds

Schnauzer (unspecified) 1
Chihuahua 1
Bichon Frise 1
Dogue de Bordeaux 1
Retriever - Labrador 1
Siberian Husky 1
Domestic Shorthair 1
Cat (unknown) 1
Beagle 1
Spaniel (unspecified) 1

Most Reported Reactions

Vomiting 3
Ataxia 3
Fever 3
Application site hair loss 2
Elevated amylase 2
Elevated globulins 2
Lethargy (see also Central nervous system depression in 'Neurological') 1
Inappetence 1
Death 1
Facial swelling (see also 'Skin') 1
Drug administration error 1
Anaphylactic-type reaction 1

Outcome Breakdown

Ongoing
7 (70.0%)
Recovered/Normal
2 (20.0%)
Died
1 (10.0%)

Data Summary

Metric Value
Total adverse event reports 10
Reports involving death 1
Case-fatality rate (reported events) 1000.0%
Distinct species in reports 2
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Nobivac Rabies Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 10 adverse event reports referencing Nobivac Rabies Vaccine, including 1 reports in which the animal died — a 1000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Nobivac Rabies Vaccine. Reported administration routes include Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Nobivac Rabies Vaccine reports are Dog (8 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Schnauzer (unspecified) (1), Chihuahua (1), Bichon Frise (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Nobivac Rabies Vaccine are Vomiting (3), Ataxia (3), Fever (3), Application site hair loss (2). Of the 10 reports with a coded outcome, Ongoing is the leading category at 70.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Nobivac Rabies Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial